Basics
Description
- An inflammatory change in the heart muscle characterized by myocyte necrosis and subsequent myocardial destruction
- Direct cytotoxic effect of causative agent followed by a secondary immune response
- True incidence is unknown because many cases are asymptomatic.
- Autopsy studies have demonstrated evidence of myocarditis in 1 " 7% of cases and >50% in HIV patients.
- Male > female (1.5:1)
- Average age of patients with myocarditis is 42 yr.
- Major cause of unexpected sudden death (15 " 20% of cases) <40 yr old
Etiology
- Viral:
- Enteroviruses (coxsackie B)
- Adenovirus
- Herpesvirus (including cytomegalovirus [CMV])
- Hepatitis C
- Influenza
- Echovirus
- Herpes simplex virus
- Varicella-zoster
- Epstein " Barr virus
- Cytomegalovirus
- Mumps
- Rubeola
- Variola/vaccinia
- Yellow fever
- Rabies
- HIV
- Bacteria:
- Diphtheria
- Tuberculosis
- Brucellosis
- Psittacosis
- Meningococcus
- Mycoplasma
- Group A streptococcus
- Protozoa:
- Leishmaniasis
- Malaria
- Toxoplasmosis in the immunocompromised host
- Treponema cruzi (Chagas disease):
- Most common cause of heart failure and myocarditis worldwide
- 20 million persons infected in Central and South America
- Trichinosis
- Trypanosomiasis
- Spirochetes:
- Borrelia burgdorferi, the spirochete agent in Lyme disease
- Syphilis
- Rickettsial:
- Scrub typhus
- Rocky Mountain spotted fever
- Q fever
- Fungal:
- Candidiasis
- Aspergillosis
- Cryptococcosis
- Histoplasmosis
- Actinomycosis
- Helminthic
- Trichinosis
- Echinococcosis
- Schistosomiasis
- Cysticercosis
- Drugs:
- Acetaminophen
- Ampicillin
- Chemotherapeutic agents (anthracyclines)
- Cocaine
- Hydrochlorothiazide
- Lithium
- Methyldopa
- Penicillin
- Sulfamethoxazole
- Sulfonamides
- Zidovudine
- Radiation
- Hypersensitivity
- Heavy metals
- Hydrocarbons
- Carbon monoxide
- Arsenic
- Autoimmune disorders:
- Systemic lupus erythematosus (SLE)
- Wegener granulomatosis
- Kawasaki disease
- Giant cell arteritis
- Sarcoidosis
- Peripartum cardiomyopathy
- Bites/stings:
- Scorpion
- Snake
- Black widow venom
Diagnosis
Signs and Symptoms
Arrhythmias (18%), dyspnea (72%), and chest pain (35%)
History
- Fatigue
- Myalgias/arthralgias
- Malaise
- Fever
- Chest pain:
- Reported in 35%
- Most commonly pleuritic, sharp, stabbing, precordial
- Dyspnea on exertion is common.
- Orthopnea and shortness of breath if congestive heart failure (CHF) is present
- Palpitations are common
- Acute coronary syndrome due to local spasm & inflammation
- Syncope:
- May signal high-grade aortic valve block or risk for sudden death from VT/VF
Physical Exam
- Fever
- Tachypnea
- Tachycardia:
- Often out of proportion to fever
- Cyanosis
- Hypotension:
- Due to left ventricular dysfunction
- Uncommon in the acute setting and indicates a poor prognosis when present
- Bibasilar crackles
- Rales
- Jugular venous distention (JVD)
- Peripheral edema
- Hepatomegaly
- Ascites
- S3 or a summation gallop if significant biventricular involvement
- Intensity of S1 may be diminished
- Murmurs of mitral or tricuspid regurgitation
- Pericardial friction rub if associated with pericarditis
- Most common cause of heart failure in previously healthy children
- Particularly infants, present with nonspecific symptoms:
- Fever
- Respiratory distress
- Poor feeding or, in cases with CHF, sweating while feeding
- New onset murmur
- Cyanosis in severe cases
Essential Workup
Diagnosis Tests & Interpretation
Lab
- Cardiac enzymes
- Troponin T: Low levels can be used to exclude myocarditis
- Troponin I specificity is 89%; sensitivity is 34%
- Creatinine kinase (elevated MB) may be elevated from myocardial necrosis
- Erythrocyte sedimentation rate (ESR) is elevated in 60% during the acute phase.
- Leukocytosis is present in 25%.
- Viral titers; cultures rarely positive
- Mycoplasma, antistreptolysin titers, cold agglutinin titer
- Hepatitis panels
- Lyme titer
- Monospot testing
- CMV serology
- Blood cultures
Imaging
- EKG:
- Sinus tachycardia most frequent finding
- Transient, nonspecific ST- and T-wave changes
- Atrial and ventricular dysrhythmias
- Heart block and conduction defects:
- 20% have a conduction delay.
- 20% have a left bundle branch block.
- CXR:
- Normal cardiac silhouette
- Pulmonary edema
- Pleural effusion
- Echocardiogram:
- Impairment of left ventricular systolic and diastolic function
- Segmental wall motion abnormalities
- Impaired ejection fraction
- Pericardial effusion
- Ventricular thrombus has been identified in 15% of patients
- Gallium67 and Indium111-labeled antimyosin antibody scans
- Gadolinium-enhanced MRI:
- Indicate cardiac inflammation and myocyte necrosis
- Cardiac MRI:
- Abnormal signal areas correlate with regions of myocarditis
- Reported 76% sensitivity, 96% specificity, and 85% diagnostic accuracy
- Considered in patients in whom the diagnosis is unclear and endocardial biopsy is planned
Diagnostic Procedures/Surgery
- Right ventricular endomyocardial biopsy:
- Appropriate in heart transplant recipients
- Polymerase chain reaction (PCR) amplification of viral genome in endomyocardial tissue
- PCR identification of a viral infection from pericardial fluid, or other body fluid sites
Differential Diagnosis
- Acute MI
- Acute and chronic pulmonary embolus
- Aortic dissection
- Adrenal insufficiency
- Environmental challenges
- Esophageal perforation/rupture/tear
- Hyperpyrexia
- Hypothermia
- Kawasaki disease
- Pericarditis
- Pneumonia
- Viral
- Bacterial
- Sepsis
- Severe hypothyroidism and hyperthyroidism
- Toxin-mediated disease
Treatment
- Avoid sympathomimetic and ²-blocker drugs.
- Patients presenting with Mobitz II or complete heart block require pacemaker placement.
Initial Stabilization/Therapy
- ABCs
- Supplemental oxygen
- Cardiac monitor
- Pulse oximetry
- IV access
Ed Treatment/Procedures
- Treat dysrhythmias.
- Transthoracic or transvenous pacing for symptomatic heart block
- Supplemental oxygen
- ACE inhibitors (captopril):
- Reduce afterload and inflammation.
- Digoxin:
- CHF or atrial fibrillation
- Diuretics (furosemide, bumetanide)
- Hyperimmunoglobulin therapy in CMV-associated myopericarditis.
- NSAIDs contraindicated in early and acute-phase myocarditis
- Heparin and warfarin for patients with depressed LV function or intracardiac thrombus
- IV immunoglobulin is an effective treatment option in pediatric viral myocarditis.
- Improved LV function and trend toward better survival
Medication
- Captopril:
- Adult dose: Initial dose 6.25 mg; can titrate to 50 mg/dose
- Pediatric dose:
- Infants: 0.15 " 0.3 mg/kg/dose (max. 6 mg/kg)
- Children: 0.5 " 1 mg/kg/24h
- Digoxin:
- Adult dose: Load: 0.4 " 0.6 mg IV, then 0.1 " 0.3 mg q6 " 8h. Maintain: 0.125 " 0.5 mg/d IV/PO
- Pediatric dose:
- <2 yr: 15 " 20 Όg/kg IV
- 2 " 10 yr: 10 " 15 Όg/kg IV
- >10 yr: 4 " 5 Όg/kg IV
- Furosemide:
- Adult dose: 20 " 80 mg/d PO/IV/IM; titrate up to 600 mg/d for severe edematous states
- Pediatric dose: 1 " 2 mg/kg PO; not to exceed 6 mg/kg; do not administer >q6h 1 mg/kg IV/IM slowly under close supervision; not to exceed 6 mg/kg
- Immunoglobulin IV (Gamimune, Gammagard, Gammar-P, Sandoglobulin):
- Adult dose: 2 g/kg IV over 2 " 5 days
Follow-Up
Disposition
Admission Criteria
Symptomatic patients with myocarditis:
- New-onset
- CHF
- Dysrhythmia
- Mobitz II or complete heart block
- Embolic events
- Cardiogenic shock
Discharge Criteria
Asymptomatic patient with no evidence of dysrhythmia or cardiac dysfunction
Issues for Referral
Cardiac transplant for patients with intractable CHF:
- Approximately 50% of patients die within 5 yr of diagnosis.
- Best prognosis for lymphocytic myocarditis
Pearls and Pitfalls
- Careful physical exam for signs of CHF and pericarditis is paramount.
- EKG should be obtained when considering the diagnosis and is especially sensitive for pediatric cases.
- Patients with evidence of dysrhythmia, CHF, or thromboembolism must be admitted.
Additional Reading
- Brady WJ, Ferguson JD, Ullman EA, et al. Myocarditis: Emergency department recognition and management. Emerg Med Clin North Am. 2004;22(4):865 " 885.
- Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526 " 1538.
- Durani Y. Pediatric myocarditis: Presenting clinical characteristics. Am J Emerg Med. 2009;27(8):942 " 947.
- Magnani JW, Dec GW. Myocarditis: Current trends in diagnosis and treatment. Circulation. 2006;113:876 " 890.
- Monney PA, Sekhri N, Burchell T, et al. Acute myocarditis presenting as acute coronary syndrome: Role of early cardiac magnetic resonance in its diagnosis. Heart. 2011;97(16):1312 " 1318.
See Also (Topic, Algorithm, Electronic Media Element)
Congestive Heart Failure
Codes
ICD9
- 074.23 Coxsackie myocarditis
- 422.91 Idiopathic myocarditis
- 429.0 Myocarditis, unspecified
- 036.43 Meningococcal myocarditis
- 422.0 Acute myocarditis in diseases classified elsewhere
ICD10
- B33.22 Viral myocarditis
- I40.0 Infective myocarditis
- I51.4 Myocarditis, unspecified
- A39.52 Meningococcal myocarditis
- A18.84 Tuberculosis of heart
- D86.85 Sarcoid myocarditis
SNOMED
- 50920009 Myocarditis (disorder)
- 89141000 viral myocarditis (disorder)
- 91025000 Idiopathic myocarditis (disorder)
- 91468009 Meningococcal myocarditis (disorder)
- 195033009 Sarcoid heart muscle disease (disorder)
- 233868005 Fungal myocarditis (disorder)
- 37217002 coxsackie myocarditis (disorder)
- 64043005 Bacterial myocarditis (disorder)